Eli Lilly (LLY) Common Equity (2009 - 2026)
Eli Lilly's Common Equity came in at $40.27 billion for Q3 2026, up 68.8% from $23.85 billion a year earlier and up 18.9% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Eli Lilly's Common Equity was $26.54 billion, up 85.9% from FY2024.
- Common Equity has increased in each of the last six years, with a five-year compound annual growth rate of 35.4% (FY2020 to FY2025).
- Going back by year, Common Equity was $14.27 billion in FY2024 (+31.4%), $10.86 billion in FY2023 (+0.8%), $10.78 billion in FY2022 (+17.7%) and $9.15 billion in FY2021 (+57.2%).
- The Q3 2026 figure represents the highest quarterly Common Equity in data going back to Q2 2009.
- Year-over-year, Common Equity has increased for 27 consecutive quarters, with growth averaging 61.5% over the last eight quarters.
- Across the past five years, year-over-year growth in Common Equity ran from 0.8% in Q4 2023 to 96.9% in Q1 2026.
- Business Quant data shows LLY's Common Equity at $33.88 billion (Q2 2026), $31.2 billion (Q1 2026) and $26.54 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 40.27 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -4.58 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 44.95 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 51.81 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 89.30 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 20.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 40.27 Bn |
| Jun 30, 2026 | 33.88 Bn |
| Mar 31, 2026 | 31.20 Bn |
| Dec 31, 2025 | 26.54 Bn |
| Sep 30, 2025 | 23.85 Bn |
| Jun 30, 2025 | 18.35 Bn |
| Mar 31, 2025 | 15.85 Bn |
| Dec 31, 2024 | 14.27 Bn |
| Sep 30, 2024 | 14.32 Bn |
| Jun 30, 2024 | 13.64 Bn |
| Mar 31, 2024 | 12.90 Bn |
| Dec 31, 2023 | 10.86 Bn |
| Sep 30, 2023 | 11.31 Bn |
| Jun 30, 2023 | 11.15 Bn |
| Mar 31, 2023 | 11.29 Bn |
| Dec 31, 2022 | 10.78 Bn |
| Sep 30, 2022 | 10.17 Bn |
| Jun 30, 2022 | 8.66 Bn |
| Mar 31, 2022 | 9.46 Bn |
| Dec 31, 2021 | 9.15 Bn |
API Access
Eli Lilly Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();